SelectQuote, Inc. Q4 2026 Earnings Call Summary

SelectQuote, Inc. reported Q4 2026 earnings, focusing on cash flow and leverage reduction. Healthcare Services became the largest revenue contributor with a $50M EBITDA run rate. Fiscal 2027 revenue is projected to decline 14% due to Medicare Advantage policy drops and the Inflation Reduction Act. Operating cash flow is expected to double to $60M, with free cash flow targeted at $50M. The company plans to reduce debt and invest in technology for efficiency gains.

Original reporting
Published Aug 27, 2026, 9:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 10:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote, Inc. Q4 2026 Earnings Call Summary — source image
Decision brief

The 30-second read

Low
01

Why it matters

Management emphasizes cash‑flow generation, leverage reduction, and AI‑enabled efficiency gains.

02

Market read

Earnings call provides fresh guidance and operational metrics that may influence the stock and sector sentiment.

03

What to watch

Potential upside from AI‑driven cost reductions and future refinancing of high‑cost debt.

Relevance 6/10Novelty 6/10Timing: post‑earnings call

Background

SelectQuote, a U.S. health‑insurance brokerage, discussed Q4 2026 results and FY2027 outlook.

Market effects

Provides insight into Medicare Advantage and healthcare services sector outlook.

Impacts U.S. healthcare services and insurance markets.

Limited to U.S. insurers; minimal global effect.

Counterpoint

Guidance suggests revenue decline, but cash flow improvements could attract value‑focused investors.

Key entities

  • SelectQuote, Inc.

    U.S. health‑insurance brokerage providing Medicare Advantage and term‑life products.

Related articles

$SLQTHighAI 8/10

SelectQuote (SLQT) Q4 2026 Earnings Call Transcript

SelectQuote reported fiscal 2026 revenue of $1.6B, up 6% YoY, with adjusted EBITDA of $109.1M. Healthcare Services revenue grew 14% to $845M. Fiscal 2027 guidance includes revenue of $1.35B-$1.45B and adjusted EBITDA of $90M-$115M. Management highlighted cash flow improvement and debt reduction strategies, noting industry volatility in Medicare Advantage.

$SLQTMedAI 8/10

SelectQuote’s (SLQT) Cash Flow Pitch Comes With A Shrinking Top Line

SelectQuote (SLQT) reported fiscal 2026 revenue of $1.62B, up 6% YoY, with operating cash flow increasing $44M. However, it posted a Q4 net loss of $16.8M and guided fiscal 2027 revenue lower. Healthcare Services revenue grew 14% to $845M, despite drug pricing changes. The company identified $30M in annual savings from AI tools. Guidance expects fiscal 2027 revenue to decline 14% at the midpoint, with Medicare Advantage policies projected to fall further.

$SLQTMedAI 8/10

SelectQuote Q4 Earnings Call Highlights

SelectQuote (SLQT) reported Q4 Healthcare Services membership at 109,000, with expected revenue decline of 10-15% in fiscal 2027 due to the Inflation Reduction Act. Senior segment revenue fell 4% to $576M but maintained 26% EBITDA margins. Life insurance revenue rose 8% to $186M. The company guided fiscal 2027 revenue at $1.35B-$1.45B and adjusted EBITDA at $90M-$115M, with cash flow doubling.

$SLQTHighAI 8/10

SelectQuote Shares Slide After Q4 Revenue Miss and Weak Fiscal 2027 Outlook

SelectQuote (SLQT) shares fell 14.69% in pre-market trading after reporting Q4 fiscal 2026 revenue of $321.7M, missing estimates, and issuing a fiscal 2027 revenue outlook of $1.35B-$1.45B, below consensus. The company reported a net loss of $16.8M, though adjusted EBITDA improved. CEO Tim Danker highlighted success in the Senior Medicare Advantage segment.

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$SLQTHigh

SelectQuote, Inc. (SLQT): Results of Operations and Financial Condition

SelectQuote, Inc. (SLQT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2026 Results Fourth Quarter of Fiscal Year 2026 – Consolidated Earnings Highlights • Revenue of $321.7 million • Net loss of $(16.8) million • Adjusted EBITDA* of $11.9 million Fiscal Year 2027 Guidance Ranges: